You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 321 Phase I clinical trial assessing the combination of systemic chemokine modulatory regimen targeting TLR3 with neoadjuvant chemotherapy in triple negative breast cancer

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Clinical trials in progress
321 Phase I clinical trial assessing the combination of systemic chemokine modulatory regimen targeting TLR3 with neoadjuvant chemotherapy in triple negative breast cancer

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 2020105015
Dec 20205005
Jan 20212603
Feb 20211402
Mar 20214605
Apr 20211404
May 2021608
Jun 2021003
Jul 2021006
Aug 2021003
Sep 2021005
Oct 202180016
Nov 202126014
Dec 20211405
Jan 20221602
Feb 2022801
Mar 20222603
Apr 20221003
May 20221601
Jun 20222401
Jul 20221402
Aug 20222803
Sep 20222604
Oct 2022802
Nov 20221607
Dec 20221801
Jan 20231000
Feb 20231600
Mar 20231602
Apr 20231404
May 20231201
Jun 2023600
Jul 20231004
Aug 20231003
Sep 20231004
Oct 20233605
Nov 20232201
Dec 20232402
Jan 2024800
Feb 20241800
Mar 20241601
Apr 20241202
May 20241400
Jun 20241801
Jul 20241400
Aug 20242200
Sep 20242402
Oct 20241005
Nov 20241204
Dec 20241805
Jan 20252404
Feb 2025006
Mar 2025006
Apr 2025007
May 2025003
Jun 2025002
Total9870198